- Home
- JHG vs CAI Comparison
JHG vs CAI Comparison
Compare JHG & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JHG | CAI |
|---|---|---|
| Founded | 1934 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.0B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | JHG | CAI |
|---|---|---|
| Price | $51.32 | $18.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $47.38 | $33.67 |
| AVG Volume (30 Days) | ★ 2.9M | 2.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | ★ 104.30 | N/A |
| EPS | ★ 5.23 | N/A |
| Revenue | ★ $1,743,700,000.00 | N/A |
| Revenue This Year | N/A | $24.26 |
| Revenue Next Year | $5.77 | $22.60 |
| P/E Ratio | $9.85 | ★ N/A |
| Revenue Growth | ★ 74.39 | N/A |
| 52 Week Low | $28.26 | $17.15 |
| 52 Week High | $53.76 | $42.50 |
Technical Indicators
Market Signals| Indicator | JHG | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 62.71 | 36.35 |
| Support Level | $42.53 | $17.15 |
| Resistance Level | $53.76 | $21.47 |
| Average True Range (ATR) | 0.73 | 1.28 |
| MACD | 0.08 | 0.15 |
| Stochastic Oscillator | 50.86 | 32.96 |
Price Performance
Historical ComparisonAbout JHG Janus Henderson Group plc
Janus Henderson Group provides investment management services to retail intermediary (50% of managed assets), self-directed (20%) and institutional (30%) clients. At the end of September 2025, active equities (52%), fixed-income (32%), balanced (12%) and alternative (4%) investment platforms constituted the company's $484 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (67%), with customers from Europe, the Middle East, Africa, and Latin America (25%) and the Asia-Pacific region (8%) accounting for the remainder.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.